Markets & Stocks

Cannabis Stocks Today — Thursday 19 November 2026: IM Cannabis trades at $0.54

Cannabis stocks sit lower on Thursday, 19 November, with the latest quotes from Finnhub largely reflecting Wednesday’s trading.

Business of Cannabis Business Brief

Cannabis stocks sit lower on Thursday, 19 November, with the latest quotes from Finnhub largely reflecting Wednesday’s trading. The AdvisorShares Pure US Cannabis ETF (MSOS) trades at $3.58, down 1.9%, while the Amplify Alternative Harvest ETF (MJ) sits at $20.03, down 2.1%. Business of Cannabis reported yesterday that AFC Gamma held above $3.50; the speciality lender now trades at $3.47, down 1.4%.

Breadth is thin. Only eight of the 35 tickers we track trade above their previous close, one (SNDL, at $1.34) is unchanged and 26 are lower. IM Cannabis (IMCC) leads the gainers, up 8.5% at $0.54, followed by Vext Science (VEXTF), up 5.4% at $0.13. On the downside, WM Technology (MAPS) is off 10.3% at $0.157, Corbus Pharmaceuticals (CRBP) is down 8.8% at $2.75 and GrowGeneration (GRWG) has lost 6.7% to $1.12. Canopy Growth (CGC) sits at $0.50, down 5.6%.

Ticker Company Current Price Change ($) Change (%)
GLASF Glass House Brands $2.26 −$0.32 −12.40%
MAPS WM Technology $0.1570 −$0.02 −10.29%
CRBP Corbus Pharmaceuticals $2.75 −$0.27 −8.80%
IMCC IM Cannabis $0.5356 +$0.04 +8.49%
GRWG GrowGeneration $1.12 −$0.08 −6.67%
CGC Canopy Growth $0.5015 −$0.03 −5.63%
VEXTF Vext Science $0.1261 +$0.01 +5.43%
VFF Village Farms $2.17 −$0.12 −5.24%
CRLBF Cresco Labs $0.4501 −$0.02 −4.64%
OGI Organigram $0.6766 −$0.03 −4.29%
TLRY Tilray Brands $2.25 −$0.10 −4.26%
TPB Turning Point Brands $47.53 −$1.98 −4.00%
JAZZ Jazz Pharmaceuticals $247.77 +$7.06 +2.93%
ACB Aurora Cannabis $4.40 −$0.12 −2.65%
IPW iPower $1.18 −$0.03 −2.48%
SMG Scotts Miracle-Gro $64.06 +$1.51 +2.41%
CURLF Curaleaf Holdings $7.76 −$0.19 −2.39%
ABBV AbbVie $286.01 −$6.81 −2.33%
CBWTF Auxly Cannabis $2.46 −$0.06 −2.22%
MJ Amplify Alternative Harvest ETF $20.03 −$0.44 −2.15%
MSOS AdvisorShares Pure US Cannabis ETF $3.58 −$0.07 −1.92%
JUSHF Jushi Holdings $0.3913 +$0.01 +1.90%
YOLO AdvisorShares Pure Cannabis ETF $2.35 −$0.04 −1.67%
MO Altria Group $76.26 −$1.20 −1.55%
AFCG AFC Gamma $3.47 −$0.05 −1.42%
CNBS Amplify Seymour Cannabis ETF $20.73 −$0.20 −0.94%
REFI Chicago Atlantic Real Estate Finance $8.70 −$0.07 −0.80%
CRON Cronos Group $3.17 −$0.02 −0.63%
IXHL Incannex Healthcare $1.75 +$0.01 +0.57%
AAWH Ascend Wellness $0.3399 −$0.00 −0.44%
HITI High Tide $2.37 +$0.01 +0.42%
STZ Constellation Brands $143.62 −$0.50 −0.35%
IIPR Innovative Industrial Properties $50.60 +$0.10 +0.20%
GTBIF Green Thumb Industries $5.95 −$0.01 −0.17%
SNDL SNDL $1.34 $0.00 0.00%

IM Cannabis trades at $0.54. Its board has approved a 1-for-3 reverse stock split, which Investing.com reports takes effect on 23 November. The company said the consolidation is intended to support compliance with Nasdaq’s $1.00 minimum bid price rule. Investing.com notes that IM Cannabis completed a 30-for-1 consolidation only in August, which removes its eligibility for the standard 180-day cure period.

Tilray Brands (TLRY) sits at $2.25, down 4.3%. That is below the $2.30 that GuruFocus cited as the stock’s 52-week low on 17 November. Shareholders re-elected Irwin Simon and two other Class II directors at Tilray’s annual meeting on 18 November, according to Rallies.

WM Technology trades at $0.157 on the OTC market. The Weedmaps owner reported a third-quarter loss of $0.04 a share against a consensus estimate of a $0.02 profit, with revenue of $38.48m short of the $39.1m forecast, Investing.com reported. No fresh filing explains today’s move.

Glass House Brands’ legacy OTC symbol (GLASF) shows $2.26, down 12.4%, but readers should treat that quote with caution. The company’s shares have traded on the New York Stock Exchange as GLAS since 30 June, Cannabis Business Times reported. Glass House’s third-quarter results, published on 16 November, showed revenue of $56.8m, up from $26.2m a year earlier, and a net loss of $10.1m.

Canada’s licensed producers are broadly weaker. Aurora Cannabis (ACB) trades at $4.40, down 2.7%, Village Farms (VFF) sits at $2.17 after a 5.2% decline and Organigram (OGI) is down 4.3% at $0.68. Cronos Group (CRON) holds at $3.17, off 0.6%, and High Tide (HITI) edges up 0.4% to $2.37. Canopy Growth, at $0.50, remains well below the $1.00 Nasdaq threshold. Corbus Pharmaceuticals, whose pipeline includes the oral obesity candidate CRB-913, sits at $2.75; we found no filing or announcement tied to its 8.8% decline.

The property and lending names are steadier. Innovative Industrial Properties (IIPR) holds above $50 at $50.60, up 0.2%, while Chicago Atlantic Real Estate Finance (REFI) sits at $8.70, down 0.8%.

Among the multi-state operators, Curaleaf (CURLF) trades at $7.76, down 2.4%, Green Thumb (GTBIF) holds at $5.95 and Jushi (JUSHF) edges up 1.9% to $0.39. Outside the core cannabis names, Scotts Miracle-Gro (SMG) rises 2.4% to $64.06 and Jazz Pharmaceuticals (JAZZ) gains 2.9% to $247.77, while AbbVie (ABBV) slips 2.3% to $286.01.

The federal backdrop remains the main reference point for the US operators. The Drug Enforcement Administration issued its first registrations to state-licensed medical dispensaries on 30 October and set a 29 November deadline for medical businesses to confirm compliant supply chains, law firm Buchalter noted. That date is ten days away; our cannabis rescheduling hub follows each step. With MSOS at $3.58 and only eight names in positive territory, the sector enters Thursday’s US session on the back foot. The next test for IM Cannabis is whether its consolidated shares hold above $1.00 once they begin trading on 23 November. Pre-market quotes will shift once trading opens, and OTC prices may lag by a day. For earlier sessions, see our daily stocks coverage. Track all cannabis stocks live on the Business of Cannabis Stocks Tracker.

TopicsAFCGCGCCRBPCRLBFGLASFGRWGIMCCMAPS

Rob Dale

Rob runs technical and SEO strategy at Business of Cannabis and has a Master’s in Clinical Exercise Physiology. He blends search know-how with a solid grasp of clinical methods to spot what actually matters in new studies and regulations. Day to day, he helps shape evidence-based explainers and features, translating data into clear, useful insights for industry pros.

More from Rob

Spotted an error, or have a tip? Contact the newsroom.

Up next · Markets & Stocks

Cannabis Stocks Today — Wednesday 18 November 2026: AFC Gamma holds above $3.50

Rob Dale · 18 November 2026

More